Cargando…
Targeting Insulin and Insulin-Like Growth Factor Pathways in Epithelial Ovarian Cancer
Ovarian cancer is the most lethal of all gynecological malignancies, due in part to the diagnosis at an advanced stage caused by the lack of specific signs and symptoms and the absence of reliable tests for screening and early detection. Most patients will respond initially to treatment but about 70...
Autores principales: | Beauchamp, Marie-Claude, Yasmeen, Amber, Knafo, Ariane, Gotlieb, Walter H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2804114/ https://www.ncbi.nlm.nih.gov/pubmed/20069126 http://dx.doi.org/10.1155/2010/257058 |
Ejemplares similares
-
Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors
por: Amin, Oreekha, et al.
Publicado: (2015) -
Targeting insulin-like growth factor pathways
por: Yee, D
Publicado: (2006) -
Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer
por: Amutha, Periyasamy, et al.
Publicado: (2017) -
Insulin/Insulin-Like Growth Factor-1 Pathway in Barrett's Carcinogenesis
por: Greer, K B, et al.
Publicado: (2013) -
Insulin-Like Growth Factor Pathway and the Thyroid
por: Smith, Terry J.
Publicado: (2021)